EP4096659A4 - SREBP INHIBITORS COMPRISING A THIOPHENIC RING - Google Patents
SREBP INHIBITORS COMPRISING A THIOPHENIC RING Download PDFInfo
- Publication number
- EP4096659A4 EP4096659A4 EP21748420.3A EP21748420A EP4096659A4 EP 4096659 A4 EP4096659 A4 EP 4096659A4 EP 21748420 A EP21748420 A EP 21748420A EP 4096659 A4 EP4096659 A4 EP 4096659A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- srebp
- inhibitors
- thiophenic ring
- thiophenic
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062966358P | 2020-01-27 | 2020-01-27 | |
| US202063056410P | 2020-07-24 | 2020-07-24 | |
| PCT/US2021/015101 WO2021154735A1 (en) | 2020-01-27 | 2021-01-26 | Srebp inhibitors comprising a thiophene central ring |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP4096659A1 EP4096659A1 (en) | 2022-12-07 |
| EP4096659A4 true EP4096659A4 (en) | 2023-10-18 |
Family
ID=77079187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP21748420.3A Withdrawn EP4096659A4 (en) | 2020-01-27 | 2021-01-26 | SREBP INHIBITORS COMPRISING A THIOPHENIC RING |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP4096659A4 (en) |
| WO (1) | WO2021154735A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024089216A1 (en) | 2022-10-27 | 2024-05-02 | Syngenta Crop Protection Ag | Novel sulfur-containing heteroaryl carboxamide compounds |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015031710A1 (en) * | 2013-08-29 | 2015-03-05 | Baylor College Of Medicine | Compositions and methods for the treatment of metabolic and body weight related disorders |
| WO2017190086A1 (en) * | 2016-04-29 | 2017-11-02 | Fgh Biotech, Inc. | Di-substituted pyrazole compounds for the treatment of diseases |
| WO2018049080A1 (en) * | 2016-09-07 | 2018-03-15 | Fgh Biotech, Inc. | Di-substituted pyrazole compounds for the treatment of diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008214095B2 (en) * | 2007-02-02 | 2014-07-10 | Baylor College Of Medicine | Compositions and methods for the treatment of metabolic disorders |
| KR20160067841A (en) * | 2013-08-28 | 2016-06-14 | 메디베이션 테크놀로지즈, 인크. | Heterocyclic compounds and methods of use |
| CA2978627A1 (en) * | 2015-03-04 | 2016-09-09 | Medivation Technologies, Inc. | Srebp blockers for use in treating liver fibrosis, elevated cholesterol and insulin resistance |
| CA2977539A1 (en) * | 2015-03-04 | 2016-09-09 | Medivation Technologies, Inc. | Sterol regulatory element-binding proteins (srebps) inhibitors |
-
2021
- 2021-01-26 EP EP21748420.3A patent/EP4096659A4/en not_active Withdrawn
- 2021-01-26 WO PCT/US2021/015101 patent/WO2021154735A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015031710A1 (en) * | 2013-08-29 | 2015-03-05 | Baylor College Of Medicine | Compositions and methods for the treatment of metabolic and body weight related disorders |
| WO2017190086A1 (en) * | 2016-04-29 | 2017-11-02 | Fgh Biotech, Inc. | Di-substituted pyrazole compounds for the treatment of diseases |
| WO2018049080A1 (en) * | 2016-09-07 | 2018-03-15 | Fgh Biotech, Inc. | Di-substituted pyrazole compounds for the treatment of diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4096659A1 (en) | 2022-12-07 |
| WO2021154735A1 (en) | 2021-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP1707203S (en) | ring | |
| JP1706911S (en) | ring | |
| JP1706905S (en) | ring | |
| JP1707066S (en) | ring | |
| JP1706899S (en) | ring | |
| JP1707206S (en) | ring | |
| JP1707200S (en) | ring | |
| JP1707075S (en) | ring | |
| EP4458777A4 (en) | PRODUCTION DEVICE | |
| CL2021001491S1 (en) | Talking. | |
| LT3990414T (en) | METHOD OF MANUFACTURING A CARBONATE-BONDED, COMPACTED PRODUCT | |
| IL286750A (en) | becomes a semiconductor | |
| EP4413158A4 (en) | B(EAD-BASED) A(TACSEQ) P(ROCESSING) | |
| EP4096659A4 (en) | SREBP INHIBITORS COMPRISING A THIOPHENIC RING | |
| EP4251372C0 (en) | Radial Press Tool | |
| EP4087724C0 (en) | TABLETTING MACHINE | |
| EP4093601C0 (en) | RADIAL PRESS | |
| EP4058014A4 (en) | SREBP INHIBITOR HAVING A THIOPHENIC RING | |
| JP1709267S (en) | ring | |
| EP4074954A4 (en) | PRESSURE RING | |
| ES1210863Y (en) | A MOBILE ELBOW. | |
| EP4135973C0 (en) | RADIAL PRESS | |
| ES1278739Y (en) | A PURSE | |
| EP4474359A4 (en) | PRODUCTION DEVICE | |
| JP1737691S (en) | die grinder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20220802 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A61K0031442700 Ipc: C07D0409040000 |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20230914 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/4436 20060101ALI20230908BHEP Ipc: A61K 31/436 20060101ALI20230908BHEP Ipc: A61P 3/06 20060101ALI20230908BHEP Ipc: A61P 1/16 20060101ALI20230908BHEP Ipc: C07D 491/056 20060101ALI20230908BHEP Ipc: C07D 409/04 20060101AFI20230908BHEP |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20240416 |